Drug intelligence / Profile preview

Fx-5A

Development stage
Unknown
Lead developer
National Institutes of Health
Modality
Nanoparticles → Drug Delivery Systems, Peptides
Administration
Intravenous
01

Overview

**Fx-5A**, also termed **5A-SM**, is an investigational synthetic high-density lipoprotein mimetic composed of the bihelical apolipoprotein A-I mimetic peptide 5A complexed with sphingomyelin. The peptide-lipid nanoparticle is designed to promote reverse cholesterol transport, principally by facilitating ATP-binding cassette transporter A1-mediated cellular cholesterol efflux. In preclinical studies, the sphingomyelin formulation increased cholesterol mobilization, enhanced ABCG1- and scavenger receptor class B member 1-mediated cholesterol efflux relative to a phosphatidylcholine formulation, reduced inflammatory cytokine release, and reduced atherosclerotic plaque burden in ApoE-deficient mice. Fx-5A has entered a Phase 1 intravenous study in healthy volunteers for cardiovascular-disease development.

Other names
5A peptide-sphingomyelin complex5A-SMFx-5A peptide complexFx5A peptide complexFx 5A peptide complex
02

Targets

ABCA1 (ATP-binding cassette transporter A1)

Beyond the preview

Go deeper on Fx-5A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fx-5A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call